Zoe Daniels joined Vernalis in 2005 through the company’s acquisition of Ionix Pharmaceuticals. Prior to that she spent several years at GSK working in ion channel drug discovery. During her time at Vernalis she has worked in several teams including assay technology, DMPK and currently SPR, gaining a wide range of technical skills in these areas. She has also been a project manager for one of the Bcl-2 family targets, working alongside our Servier collaborators and currently manages a team of DMPK, SPR, ITC and cell culture specialists.
